Efficacy of topical epidermal growth factor cream for patients with epidermal growth factor receptor inhibitor-induced acneiform eruption: a randomized controlled trial

Br J Dermatol. 2020 Jan;182(1):219-221. doi: 10.1111/bjd.18340. Epub 2019 Sep 2.

Authors

J H Lee¹, H J Ju¹, H S Kwon¹, H M Jung¹, G M Kim¹, J M Bae¹, H J An²

Affiliations

¹ Department of Dermatology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
² Division of Medical Oncology, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

PMID: 31301244
DOI: 10.1111/bjd.18340

No abstract available

Publication types

Letter
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Acneiform Eruptions* / chemically induced
Acneiform Eruptions* / drug therapy
Antineoplastic Agents* / therapeutic use
Cetuximab
Epidermal Growth Factor
ErbB Receptors
Humans
Protein Kinase Inhibitors / therapeutic use

Substances

Antineoplastic Agents
Protein Kinase Inhibitors
Epidermal Growth Factor
ErbB Receptors
Cetuximab

Grants and funding